Predictive Biomarkers: Progress on the Road to Personalized Cancer Immunotherapy
J Natl Cancer Inst
.
2021 Nov 29;113(12):1601-1603.
doi: 10.1093/jnci/djab068.
Author
Leisha A Emens
1
Affiliation
1
Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
PMID:
33823004
PMCID:
PMC8634411
DOI:
10.1093/jnci/djab068
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers
Genomics
Humans
Immune Checkpoint Inhibitors*
Immunotherapy
Neoplasms* / genetics
Neoplasms* / immunology
Neoplasms* / therapy
Substances
Immune Checkpoint Inhibitors
Biomarkers